NEW PHARMACOLOGYCAL APPROACH IN GLAUCOMA TREATMENT USING SOL. XALATAN WHICH IS REGISTERED AS A FIRST CHOICE REMEDY IN EU. Case repport of the high iris insertion.

S. Elek-Vlajić
S. Elek-Vlajić

Ophtalmology department, Health Center , Kosovska Mitrovica , Kosovo*

Published: 01.12.2004.

Volume 32, Issue 2 (2004)

pp. 93-96;

https://doi.org/10.70949/pramed200402100E

Abstract

Trabeculodisgenesis of the primary congenital glaucoma because of the iris affiliate in front of the scleral ridge in
angulus iridocornealis. It is treated both surgically and with medication. We have showed you a patient which has, by the
time of illness diagnosing, developed morphological and functional optic papilla damages. We have applied both
comparative examinations and x-rays before and after sol. Xalatan therapy. With the research which is stillin progress, it is
estabilished that the values of intraocular pressure are brought to statistically normal frame (1,3 kPa-2,9kPa) and the
progression of both eyes´ optic nerves ganglion cells decadance is reduced, too

Keywords

References

1.
Asrani S, Zeimer R, Wilensky J. - Студија о великим дневним флуктуацијама интраокуларног притиска као независном ризичном фактору за пацијенте са глаукомом. J Glaucoma. 9:134–42.
2.
Cvetković D, Kontić Đ, Hentova-Senaćanić P. Књига о глаукому: дијагноза и лечење, Завод за уџбенике и наставна средства.
3.
Schaefer CP D, KM B, K P. - Клинички и економски исходи повезани са иницијалним лечењем глаукома: подаци из мултинационалне ретроспективне кохортне студије. October. 31.
4.
file D. Summary report on benchmark studies 1999-2002. - Извештај о камен-темељцима студија.
5.
Gandolfi S, Simmons ST, Sturm R. - Тродневна компарација биматопроста и латанопроста код пацијената са глаукомом и окуларном хипертензијом. Advances in Therapy. 18:110–21.

Citation

Copyright

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Indexed by